Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/05/30 | Phase 1 | Not yet recruiting | Suzhou Genhouse Bio Co., Ltd. | ||
2024/03/08 | Phase 3 | Recruiting | |||
2024/01/31 | Phase 1 | Completed | |||
2023/12/12 | Phase 1 | Recruiting | |||
2023/10/27 | Phase 1 | Completed | |||
2022/08/08 | Phase 1 | Terminated | |||
2022/05/20 | Phase 1 | Completed | |||
2022/05/18 | Phase 1 | Active, not recruiting | |||
2020/10/14 | Phase 1 | Active, not recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Garsorasib Tablets | 国药准字H20240037 | 化学药品 | 片剂 | 11/5/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||